Phase Genomics was founded with the mission of maximizing the impact of genomics on society. With the vast majority of biological information remaining un-explored, we seek to empower researchers to make breakthrough discoveries using the power of advanced, next-generation genomic tools. The cornerstone of our approach lies in a technology called proximity ligation, which enables unprecedented improvements in the depth and quality of information generated from DNA sequencing efforts. From the discovery of thousands of new bacteria from microbiome samples to platinum quality genome assemblies, our wet lab and computational tools add a new dimension to genomic information. By continuously developing new genomic methods, we seek to bring transformative change to research, industry, and the clinic.

Phase Genomics applies Hi-C and other proximity ligation methods to enable metagenomic deconvolution, chromosome-scale genome assembly, as well as analysis of structural variation and genome architecture. We offer a comprehensive portfolio of laboratory and computational services and products. These include proximity ligation (Hi-C) kits for plants, animals, microbes, and human samples, as well as industry-leading genome and metagenome assembly and analysis software. Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company’s mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.

WomenHack

Discover and rate companies that empower women in tech

Phase Genomics

Phase Genomics

Welcome Back!